# Sunland Fund

> Sunland Fund is a VC fund in Shanghai backing Health Care and Medical. See 35 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 35
- Last investment: Jul 2026
- Lead investor: 46%
- Last updated: Aug 2026
- Website: http://www.sunlandfund.com/

Sunland Fund is a VC fund in Shanghai focused on Health Care and Medical. Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

## Contacts

5 contacts available for Sunland Fund. Shizune tracks 2 team members at Sunland Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sunland-fund?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.4M–$14M |
| Series A | $1.4M–$16M |
| Series B | $2.8M–$28M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 20 | 57% |
| Medical | 18 | 51% |
| Medical Device | 12 | 34% |
| Biotechnology | 9 | 26% |
| Manufacturing | 8 | 23% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 10 | 29% |
| Series B | 10 | 29% |
| Seed | 7 | 20% |
| Series C | 5 | 14% |
| Angel | 1 | 3% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daozhi Liu | Founder | 2 | https://shizune.co/investors/profile/daozhi-liu |
| Gu Shenghan | Executive Director | 6 | https://shizune.co/investors/profile/gu-shenghan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Insight Technology | Insight Technology is an instrument manufacturer and seller company that specializes in instrument sales, intelligent instrument sales, mechanical equipment research and development, and more. |  | Seed | Jul 07, 2026 |  |
| Bochuang Biotechnology | Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions. |  | Seed | Mar 11, 2026 |  |
| Yangshan Medical Technology | Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots. |  | Seed | Feb 06, 2026 |  |
| Aopeng Yiliao | Aopeng Yiliao is a developer of vascular interventional surgery robots. | $13.7M | Series C | Apr 21, 2025 |  |
| Zhitong Technology | Zhitong Medical is a provider of computational imaging technology that focuses on the development of surgical vision. | $13.7M | Series A | Dec 16, 2024 |  |
| Medtech Technology | Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture. | $28.2M | Series B | Sep 14, 2024 |  |
| Better Medtech | Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies. | $14.1M | Seed | Jan 12, 2024 |  |
| Juhe Biotechnology | Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies. | $14M | Series B | Dec 27, 2023 |  |
| JH Cispoly | JH Cispoly develops diagnostic technology and equipment for gynecological tumors. |  | Series B | Dec 27, 2023 |  |
| Precedo Biomedical | Precedo Biomedical is a high-tech business that specializes in industrial safety & national strategic biosafety through core cell engineering technologies. It employs the innovation-driven development approach, which leverages scientific and technological innovation to propel industrial innovation, to conduct industrialization and scientificresearch centered on "cell" issues that impede biomedical development. | $13.8M | Series B | Nov 14, 2023 |  |

10 of 35 investments shown.

## Co-investors
- [Longpan Investment](https://shizune.co/investors/profile/longpan-investment) — VC Fund, 2 deals together
- [Prosperity7 Ventures](https://shizune.co/investors/profile/prosperity7-ventures-d527) — VC Fund, 2 deals together
- [SZHTI Group](https://shizune.co/investors/profile/szhti-group) — VC Fund, 2 deals together
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [Aibo Qingshi Venture Capital Fund](https://shizune.co/investors/profile/aibo-qingshi-venture-capital-fund) — VC Fund, 1 deal together
- [AriMed Advisors](https://shizune.co/investors/profile/arimed-advisors) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Medical VC Funds in Asia](https://shizune.co/investors/medical-vc-funds-asia)
- [Medical Investors in China](https://shizune.co/investors/medical-investors-china)
- [Medical VC Funds in China](https://shizune.co/investors/medical-vc-funds-china)
- [Medical Investors in Asia](https://shizune.co/investors/medical-investors-asia)

## FAQ

### What does Sunland Fund invest in?

Sunland Fund invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series B stage. Most of the 35 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Sunland Fund's check size?

Sunland Fund typically joins rounds of $1.4M–$14M at Seed, $1.4M–$16M at Series A and $2.8M–$28M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sunland Fund participates in.

### How do I contact Sunland Fund?

Public channels for Sunland Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Sunland Fund?

The team at Sunland Fund includes Daozhi Liu (Founder) and Gu Shenghan (Executive Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co